FindTrial
Sign In

Effects of early continuous blood purification on prognosis and inflammatory factors in patients with severe acute pancreatitis.

Effects of early continuous blood purification on prognosis and inflammatory factors in patients with severe acute pancreatitis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052765
Enrollment
Unknown
Registered
2021-11-05
Start date
2021-11-10
Completion date
Unknown
Last updated
2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe acute pancreatitis (SAP)

Interventions

Early blood purification group:None
Advanced blood purification group:None

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the SAP diagnostic criteria; 2. Aged > 18 years; 3. The onset time is less than 96 hours; 4. Apply blood purification treatment.

Exclusion criteria

Exclusion criteria: 1. Incomplete medical records; 2. Pregnancy complicated with acute pancreatitis; 3. There is a history of chronic diseases such as chronic lung disease or left ventricular insufficiency, renal failure or other conditions; 4. There is a history of chronic pancreatitis in the past; 5. After blood purification treatment in a foreign hospital; 6. The hospital stay is less than 48 hours.

Design outcomes

Primary

MeasureTime frame
3-month mortality;—

Secondary

MeasureTime frame
ICU length of stay;treatment effect;IL-6;TNF-a;—

Countries

China

Contacts

Public ContactYe Ying

Affiliated Hospital of Xuzhou Medical University

xzmcyy@163.com+86 18052268313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026